SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Seegene/Lab901 brings a New Detection Platform for Multiple Pathogens to European Hospitals

Seegene Inc
18 Jun 2008

Product news

Seegene and Lab901 today announced the availability of a novel automated multi-pathogen walk-away detection platform for European hospitals. Based on the Seeplex® multiplexing PCR system and ScreenTape® gel electrophoresis detection system, this new Seeplex/ScreenTape detection platform will be introduced to clinical and research laboratories in 10 countries across Europe beginning this month.

Seegene and Lab901 have agreed to co-market the testing solutions in the European market. The two companies are responding to requests in Europe for a new automated testing technique to perform what is a routine, but not always consistent, test for biological agents in clinics. Hospital centers in The Netherlands, United Kingdom, Spain, Italy, Norway, Greece, Austria, France, Israel and Turkey have started demonstrations of the automated Seeplex/ScreenTape system.

"As active pathogenic surveillance becomes the norm for healthcare regimes worldwide, clinical research and reference labs will be placed under increased pressure to perform. It is essential that these labs gain the tools and systems that enable them to increase the speed and efficiency of pathogen detection," said Dr. Jong-Yoon Chun, Founder and Chief Executive Officer, Seegene. "The automated Seeplex/ScreenTape system sets a new standard for automated detection ease of use and performance."

"The simplicity, speed and sample traceability of the Seeplex/ScreenTape system is clearly of real value to diagnostic microbiology and virology laboratories," said Joel Fearnley, Co-founder and Chief Executive Officer of Lab901. “The ScreenTape system optimized for Seeplex multi-pathogen tests will help speed up discovery and diagnostic procedures."

The automated Seeplex/ScreenTape tests are based on a Seeplex multiplexing PCR technology from Seegene, which is capable of detecting multiple pathogens in a single tube, and ScreenTape®, an automated walk-away gel electrophoresis detection system from Lab901.

The Seeplex tests with the CE mark and ISO 13485 deliver maximum specificity, reproducibility and sensitivity and can be applied to a broad range of molecular diagnostics, including human, animal, plant and microorganisms. The ScreenTape system will automate the simultaneous analysis of eight or sixteen Seeplex PCR samples. Processing speed for 8 samples is completed within 10 minutes; 16 samples within 18 minutes. ScreenTape displays results using an easy to interpret positive and negative read out. With no gel or buffer preparation and no system priming, even untrained operators can rapidly generate accurate and reproducible test data.

The automated Seeplex/ScreenTape tests are currently available for sexually transmitted diseases (STD), human papillomavirus (HPV), respiratory viruses (RV) and bacterial pneumonia (PB). In addition, further automated Seeplex tests are under development and will be available soon. Particularly, hospitals have showed high interest for the single tube Seeplex Sepsis test scheduled for July release.

Links

Seegene IncCompany website

Tags

ElectrophoresisElectrophoresis equipment is used to separate mixtures of protein, DNA or RNA, based on their electric charge, size and other physical characteristics, by passing them through a medium such as a polyacrylamide gel, an agarose gel or a capillary tube. Electrophoresis equipment includes horizontal and vertical gel electrophoresis chambers, isoelectric focusing systems, 2D electrophoresis and capillary electrophoresis instruments. Precast gels with a gradient can be used or gels can be hand cast. Samples are run alongside ladders or markers to identify the approximate size of a molecule. Separated proteins and nucleic acids in the gel can be stained or probed with fluorescent markers and then imaged and detected using gel documentation instruments, transilluminators, densitometers and scanners. Find the best electrophoresis equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.PCR and Thermal CyclingPolymerase chain reaction (PCR) kits and thermal cyclers are used for the in vitro amplification of DNA permitting subsequent analysis and experimental procedures. Explore a range of high-quality polymerase, primers and nucleotides or simplify your workflow with a PCR mastermix. Find reverse transcription PCR (RT-PCR) and cDNA synthesis kits for RNA products and libraries. Quantitatively measure the amplification of DNA with real-time PCR (qPCR) and droplet digital PCR (ddPCR) kits and systems, and discover automated PCR setup solutions to increase throughput. Alternative DNA amplification methods also include recombinase polymerase amplification (RPA) kits. Find the best PCR kits and thermal cyclers and purification equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.

Related articles

Seegene/Lab901 brings a New Detection Platform for Multiple Pathogens to European Hospitals